NCCS presents third annual Ellen Stovall Award to Gay Crawford and Norman Coleman

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Coalition for Cancer Survivorship presented the third annual Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care to Gay Crawford, founding director of Cancer CAREpoint, and Norman Coleman, senior investigator at NCI.

Since her diagnosis of breast cancer at age 30, Crawford spent the last 44 years playing a leadership role in bringing patient-focused cancer care to the Silicon Valley area. She helped found and lead numerous organizations, including the non-profit organization Cancer CAREPoint, which provides a wide-range of cancer support services in Silicon Valley free of charge.

Coleman is the director of the Radiation Oncology Sciences Program. Coleman leads a laboratory at NCI focusing on radiation-induced molecular and immunotherapy targets.

Named for former NCCS CEO, Ellen Stovall, who died in 2016 due to complications from three cancer treatments, the award seeks to highlight those who continue Ellen’s work of transforming cancer care to further incorporate patients’ goals, needs, and values.

More information about Crawford, Coleman, and the Ellen Stovall Award can be found here.

Table of Contents

YOU MAY BE INTERESTED IN

Earlier this week, Robert F. Kennedy Jr. was confirmed as secretary of Health and Human Services amid many resignations at federal health agencies and cancellations of NIH and NCAB meetings. All of this happened at a time when the Trump administration is reportedly preparing to fire thousands of HHS workers.
Fifty-four years ago, in his State of the Union Message in January 1971, President Nixon proposed a visionary and vigorous new challenge.  He said “The time has come in America when the same kind of concentrated effort that split the atom and took man to the moon” should be applied to finding a cure for cancer.  He followed up by requesting an appropriation of $100 million, and the promise to ask for whatever additional funds could be effectively used.  

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login